These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7325724)

  • 1. [Heparin and fibrinolysis inhibitors].
    Villaverde CA; Badimón L; Vidal M; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):97-100. PubMed ID: 7325724
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of sodium heparin on activated fibrinolysis in the rat in vivo].
    Badimón L; Villaverde C; Badimón JJ; Vidal M; Valdecasas FG
    Arch Farmacol Toxicol; 1981 Apr; 7(1):105-8. PubMed ID: 7325697
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of non-enzymatic inhibitor of fibrinolysis from the splenic tissue on the activity of the heparin-antithrombin III-thrombin complex in vitro and during activation of the anticoagulation system].
    Liapina LA; Pastorova VE; Kudriashov BA
    Fiziol Cheloveka; 1988; 14(4):629-34. PubMed ID: 3215406
    [No Abstract]   [Full Text] [Related]  

  • 4. [Neutralization of thrombin by antithrombin III in the presence of heparin in cobra venom poisoning].
    Pastorova VE
    Fiziol Zh SSSR Im I M Sechenova; 1983 Oct; 69(10):1368-71. PubMed ID: 6641987
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct inhibition of protein Ca by site directed thrombin inhibitors: implications in anticoagulant and thrombolytic therapy.
    Callas DD; Fareed J
    Thromb Res; 1995 Jun; 78(5):457-60. PubMed ID: 7544924
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of heparin and AMCA on coagulation and fibrinolysis in blood and lymph following massive haemorrhage in dogs.
    Leandoer L; Bergentz SE; Nilsson IM
    Acta Chir Scand; 1969; 135(1):1-6. PubMed ID: 5805939
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neutralization of the nonenzymatic fibrinolytic activity of complex heparin compounds by platelet factor 4].
    Liapina LA; Pastorova VE
    Gematol Transfuziol; 1988 Nov; 33(11):42-4. PubMed ID: 3234727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Heparin-adrenaline complex as a humoral agent of the anticoagulation system].
    Kudriashov BA; Liapina LA
    Vopr Med Khim; 1971; 17(1):46-53. PubMed ID: 5555145
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of antiplasmin on fibrinolysis and fibrinogenolysis].
    Bratus' GM; Byshevskiĭ ASh
    Ukr Biokhim Zh; 1971; 43(2):178-82. PubMed ID: 4254692
    [No Abstract]   [Full Text] [Related]  

  • 10. [New problems of wound healing].
    Hernández-Richter HJ; Struck H
    Int Surg; 1967 Oct; 48(4):385-90. PubMed ID: 6050549
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antifibrinolytic effect of heparin].
    Rozenfel'd MA; Leonova VB; Khavkina LS; Meshkov BB
    Biokhimiia; 1984 Oct; 49(10):1672-8. PubMed ID: 6240283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of combined administration of EACA and heparin on thrombus weight and fibrinolysis. An experimental study.
    Komatsu K; Hayakawa D; Suzuki K; Tomita S; Fukushima Y
    Bull Tokyo Med Dent Univ; 1973 Mar; 20(1):93-104. PubMed ID: 4515656
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood clotting diagnosis with chromogenic substrates].
    Róka L; Rasche H
    Internist (Berl); 1980 Apr; 21(4):189-94. PubMed ID: 6998907
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on pharmacological modification of the localized Sanarelli-Shwartzman phenomenon].
    Haustein KO; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 97(1):104-8. PubMed ID: 4114578
    [No Abstract]   [Full Text] [Related]  

  • 16. [The inhibitors of fibrinolysis].
    Badimón L; Villaverde CA; Bastida E; Badimón JJ; Valdecasas FG
    Arch Farmacol Toxicol; 1978 Apr; 4(1):98-9. PubMed ID: 697408
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibrinolytic inhibitors].
    Nagamatsu A
    Saishin Igaku; 1966 Feb; 21(2):320-5. PubMed ID: 5966316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antifibrinolytic agents, a new class of drugs].
    Markwardt F
    Internist (Berl); 1966 Aug; 7(8):400-5. PubMed ID: 4863412
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibitor of fibrinolysis from pancreas pantrypin].
    Lakin KM; Efimov VS; Polonskaia LB
    Farmakol Toksikol; 1969; 32(6):712-5. PubMed ID: 5381603
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological study of some inhibitors of fibrinolysis].
    Gavrilov AP
    Farmakol Toksikol; 1967; 30(4):460-3. PubMed ID: 5598902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.